Modeling of PET data in CNS drug discovery and development

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.40, Iss.3, 2013-06, pp. : 267-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacophore Modeling in Drug Discovery and Development: An Overview

Medicinal Chemistry, Vol. 3, Iss. 2, 2007-03 ,pp. : 187-197

Bentham Science Publishers

Access to resources Recommend Favorite

Modeling and simulation for drug discovery and development: current practices and opportunities for advancement

By Thouin Mark F

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 591-593

Informa Healthcare

Access to resources Recommend Favorite

An overview of CNS drug discovery at Eli Lilly and Company

By Paul S.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 254-254

Elsevier

Access to resources Recommend Favorite

Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 102-122

Bentham Science Publishers

Access to resources Recommend Favorite

CNS Drug Development - Lost in Translation?

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-01 ,pp. : 959-970

Bentham Science Publishers

Access to resources Recommend Favorite